June 21 (Reuters) - Eli Lilly Canada
* Eli Lilly Canada says Health Canada has granted approval
for Taltz for treatment of moderate-to-severe plaque psoriasis
Source text for Eikon: ID:nCNW7BJcPa
Further company coverage: LLY.N
(Bengaluru Newsroom; +1 646 223 8780; )